1. Market Research
  2. > Pathology
Customer Support

Talk to Ahmad

+1 718 618 4302

Industries

  • All
    • Lung Cancer

Top Countries

  • All
    • Australasia
2 reports for Lymphoma (page 1)

Purchase Reports From Reputable Market Research Publishers

Hutchison MediPharma Ltd - Product Pipeline Review - 2016

  • $ 1500
  • December 2016
  • 49 pages

This study is in patients with relapsed and/ or refractory B-cell non-Hodgkin s lymphoma or chronic lymphocytic leukemia for whom there is no standard therapy.

  • Lung Cancer
  • Lymphoma
  • Therapy
  • Australasia
  • Hutchison MediPharma Limited

Delta Like Protein 4 (Delta Like Ligand 4 or Drosophila Delta Homolog 4 or DLL4) - Pipeline Review, H2 2016

  • $ 3500
  • September 2016
  • 51 pages

The Phase II " DENALI" trial is expected to enroll approximately ## patients with first-line metastatic Stage IV non-squamous NSCLC whose tumors do not have an epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase (ALK) mutation.

  • Hospital
  • Lung Cancer
  • Therapy
  • Australasia
  • OncoMed Pharmaceuticals, Inc.


View report >

Lung Cancer Statistics

  • November 2011
  • 206 pages

The most common types are lymphomas, lymphoid leukaemia and myeloma.

  • Hospital
  • Lung Cancer
  • Lymphoma
  • Australasia
  • Australia

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on